EFFECTS OF CORTICOTROPIN-RELEASING HORMONE ON ACTH, CORTISOL AND 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E(2) IN PATIENTS WITH DIABETES-INSIPIDUS BEFORE AND AFTER CAPTOPRIL TREATMENT
S. Zacharieva et al., EFFECTS OF CORTICOTROPIN-RELEASING HORMONE ON ACTH, CORTISOL AND 13,14-DIHYDRO-15-KETO PROSTAGLANDIN E(2) IN PATIENTS WITH DIABETES-INSIPIDUS BEFORE AND AFTER CAPTOPRIL TREATMENT, Prostaglandins, leukotrienes and essential fatty acids, 54(6), 1996, pp. 433-437
A corticotropin-releasing hormone (CRH) test was performed on 7 patien
ts with central diabetes insipidus (DI) and on 7 healthy subjects. The
test was repeated on the patients with DI after 3 days of oral treatm
ent with captopril at a dose of 100 mg daily. No significant differenc
e in the responses of plasma ACTH and cortisol to CRH between the pati
ents and the controls was found. The short-term captopril treatment re
sulted in a significant decrease of both basal and CRH-stimulated ACTH
and cortisol;levels in the patients with DI. CRH did not induce any c
hanges in the stable metabolite of prostaglandin E(2) 13,14-dihydro-15
-keto-prostaglandin E(2) (PGE(2)-M) in the patients with DI before or
after the captopril treatment. The results obtained suggest that vasop
ressin is not an obligatory factor for a normal ACTH response to CRH.
Angiotensin II (A II) is involved in the regulation of ACTH. This stud
y confirmed our previous data showing the lack of any specific effect
of CRH on PGE(2) production.